Amylyx Pharmaceuticals, Inc. AMLX
31.80 USD +0.89 (+2.88%)
At closeNov 11, 2026, 4:00 PM EST
31.80 0.00 0.00%
After hours · Nov 11, 4:00 PM ET
30.46 Day range 31.88
10.83 52-week range 41.14
- YTD
- +163.25%
- 1 year
- +150.79%
AMLX revenue history
Revenue is income from the company’s ordinary business activities.
0 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 0 | -87,371,000 | -100.00% |
| FY 2024 | 2024-12-31 | 87,371,000 | -293,415,000 | -77.06% |
| FY 2023 | 2023-12-31 | 380,786,000 | 358,556,000 | 1612.94% |
| FY 2022 | 2022-12-31 | 22,230,000 | 21,945,000 | 7700.00% |
| FY 2021 | 2021-12-31 | 285,000 | -365,000 | -56.15% |
| FY 2020 | 2020-12-31 | 650,000 | -776,000 | -54.42% |
| FY 2019 | 2019-12-31 | 1,426,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-08-09T06:01:06.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.